BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arega AM, Pattanaik KP, Nayak S, Mahapatra RK. Computational discovery and ex-vivo validation study of novel antigenic vaccine candidates against tuberculosis. Acta Trop 2021;217:105870. [PMID: 33636152 DOI: 10.1016/j.actatropica.2021.105870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Arega AM, Dhal AK, Nayak S, Mahapatra RK. In silico and in vitro study of Mycobacterium tuberculosis H37Rv uncharacterized protein (RipD): an insight on tuberculosis therapeutics. J Mol Model 2022;28:171. [PMID: 35624324 DOI: 10.1007/s00894-022-05148-1] [Reference Citation Analysis]
2 Das NC, Chakraborty P, Bayry J, Mukherjee S. In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein. Front Immunol 2021;12:782506. [PMID: 35082779 DOI: 10.3389/fimmu.2021.782506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Gao Z, Shao JJ, Zhang GL, Ge SD, Chang YY, Xiao L, Chang HY. Development of an indirect ELISA to specifically detect antibodies against African swine fever virus: bioinformatics approaches. Virol J 2021;18:97. [PMID: 33952293 DOI: 10.1186/s12985-021-01568-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]